Zevia PBC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Zevia PBC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $161.26M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $155.05M | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | $37.79M | Mar 6, 2024 |
| FY2023 | Sep 30, 2023 | $43.09M | Mar 6, 2024 |
| FY2023 | Jun 30, 2023 | $42.24M | Mar 6, 2024 |
| FY2023 | Mar 31, 2023 | $43.30M | Mar 6, 2024 |
| FY2023 | Dec 31, 2022 | $35.37M | Mar 6, 2024 |
| FY2023 | Sep 30, 2022 | $44.24M | Mar 6, 2024 |
| FY2023 | Jun 30, 2022 | $45.54M | Mar 6, 2024 |
| FY2023 | Mar 31, 2022 | $38.03M | Mar 6, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $161.26M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $155.05M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $166.42M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $163.18M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $138.17M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $110.03M | Mar 11, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.42M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $71.93M | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | $15.39M | Mar 6, 2024 |
| FY2023 | Sep 30, 2023 | $19.57M | Mar 6, 2024 |
| FY2023 | Jun 30, 2023 | $19.69M | Mar 6, 2024 |
| FY2023 | Mar 31, 2023 | $20.11M | Mar 6, 2024 |
| FY2023 | Dec 31, 2022 | $15.65M | Mar 6, 2024 |
| FY2023 | Sep 30, 2022 | $19.17M | Mar 6, 2024 |
| FY2023 | Jun 30, 2022 | $19.32M | Mar 6, 2024 |
| FY2023 | Mar 31, 2022 | $15.88M | Mar 6, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($9.92M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($20.01M) | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | ($9.15M) | Mar 6, 2024 |
| FY2023 | Sep 30, 2023 | ($11.25M) | Mar 6, 2024 |
| FY2023 | Jun 30, 2023 | ($5.01M) | Mar 6, 2024 |
| FY2023 | Mar 31, 2023 | ($2.91M) | Mar 6, 2024 |
| FY2023 | Dec 31, 2022 | ($6.17M) | Mar 6, 2024 |
| FY2023 | Sep 30, 2022 | ($9.20M) | Mar 6, 2024 |
| FY2023 | Jun 30, 2022 | ($14.80M) | Mar 6, 2024 |
| FY2023 | Mar 31, 2022 | ($17.49M) | Mar 6, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.79M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($23.65M) | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | ($8.90M) | Mar 6, 2024 |
| FY2023 | Sep 30, 2023 | ($11.42M) | Mar 6, 2024 |
| FY2023 | Jun 30, 2023 | ($5.38M) | Mar 6, 2024 |
| FY2023 | Mar 31, 2023 | ($3.25M) | Mar 6, 2024 |
| FY2023 | Dec 31, 2022 | ($6.35M) | Mar 6, 2024 |
| FY2023 | Sep 30, 2022 | ($9.22M) | Mar 6, 2024 |
| FY2023 | Jun 30, 2022 | ($14.74M) | Mar 6, 2024 |
| FY2023 | Mar 31, 2022 | ($17.56M) | Mar 6, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.70M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($1.02M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($16.27M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($20.78M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | ($17.81M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($3.26M) | Mar 11, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $307.0K | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $283.0K | Feb 25, 2026 |
| FY2022 | Dec 31, 2022 | $2.59M | Mar 10, 2023 |
| FY2022 | Dec 31, 2021 | $3.14M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $805.0K | Mar 11, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.62M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $67.95M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $90.86M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $98.93M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $124.99M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $49.96M | Mar 11, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.02M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $25.01M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $29.09M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $17.15M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $20.43M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $14.31M | Mar 11, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.04M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $64.88M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $89.88M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $109.95M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $128.48M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($196.81M) | Mar 11, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($131.26M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($121.34M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($101.34M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($79.84M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | ($45.99M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 11, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.35M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $30.65M | Feb 25, 2026 |
| FY2021 | Dec 31, 2021 | $43.11M | Mar 11, 2022 |
| FY2021 | Dec 31, 2020 | $14.94M | Mar 11, 2022 |
| FY2021 | Dec 31, 2019 | $3.24M | Mar 11, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Mar 6, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Mar 6, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Mar 6, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Mar 6, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Mar 6, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Mar 6, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Mar 6, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Mar 6, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Mar 6, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Mar 6, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Mar 6, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Mar 6, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Mar 6, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Mar 6, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Mar 6, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Mar 6, 2024 |